for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Valeant cuts forecasts again

Posted

Quarterly earnings at the embattled drug maker swung from a profit to a loss. Valeant's stock has fallen 90 percent since August. Fred Katayama reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up